UNSPSC 51285313: Nifurimide

This classification denotes a topical anti-infective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) NII0A33SQL. European Medicines Agency schedules Nifurimide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09266MIG. Nifurimide generally arises in the molecular formula C9H10N4O4. The term NIFURIMIDE is an International Non-Proprietary Name or INN. NIFURIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations, for tariff and trade purposes, schedule nifurimide under HS 29349990 and SITC 51579. As of Q4 2014, NIFURIMIDE remains US FDA's Preferred Term for this commodity. Nifurimide bears US NLM identifiers UMLS ID C2983966 and NCI Concept Code C90980. SMILES: O=C1N(/N=C/C2OC([N](=O)O)CC2)C(CN1)C.

UNSPSC 51285313 Nifurimide is a Commodity code that describes pharmaceutical ingredients and active pharmaceutical compounds; however, recent state and local solicitations tagged under this code do not reflect procurement of nifurimide specifically, but rather broader medical, pharmaceutical, and emergency health supplies including naloxone, over-the-counter products, generic multi-source pharmaceuticals, and medical consumables for fire and rescue operations. The code appears to capture a mix of pharmaceutical procurement activity across health departments, emergency services, and cooperative purchasing alliances, though the actual goods being bought diverge significantly from the narrow ingredient scope the code name suggests.

Recent activity spans county health departments, state HHS agencies, municipal fire departments, and regional cooperative purchasing vehicles. Seminole County, Florida issued an IFB on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline; the City of Tampa Purchasing Department issued an IFB in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, designated as a sheltered market procurement for certified Small Local Business Enterprises with an estimated contract value of $700,000; the Texas Health and Human Services Commission issued an RFI in April 2026 seeking vendor capabilities for direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP in January 2026 with a March 26, 2026 response deadline for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon. Geographic activity centers on Florida, Texas, and Minnesota, with multi-state reach through cooperative purchasing mechanisms.